The bile duct is a tube that connects the liver and gallbladder to the small intestine. It helps carry bile from the liver to the small intestine to help digest fats. Bile duct cancer, also known as cholangiocarcinoma, is a rare type of cancer that forms in the bile duct. The major types of bile duct cancer include intrahepatic bile duct cancer, which forms inside the liver, and extrahepatic bile duct cancer, which forms outside the liver in the bile duct. Bile duct cancer often does not cause any signs or symptoms in the early stages. However, as the cancer grows and spreads, common symptoms may include jaundice, itchy skin, weight loss, abdominal pain, and fatigue. Bile duct cancer screening tools are limited due to the rarity and complexity of the disease.
The global Bile Duct Cancer Market is estimated to be valued at US$ 235.9 Mn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing prevalence of risk factors associated with bile duct cancer such as primary sclerosing cholangitis (PSC), liver fluke infections, old age, and smoking is contributing to the growth of the bile duct cancer market. According to the American Cancer Society, around 8,000 new cases of bile duct cancer are reported each year in the United States. The increasing adoption of advanced diagnostic tools such as MRI, MRCP, ERCP and technologies like intraductal ultrasound have enabled early and accurate diagnosis of bile duct cancer and are supporting early intervention and treatment. This has boosted the growth of the bile duct cancer market. Novel targeted therapies and immunotherapies are being developed and tested for the treatment of bile duct cancer which is also fuelling market growth.
SWOT Analysis
Strength: Bile Duct Cancer market is niche but growing rapidly year on year owing to rise in cases. Advancements in diagnostic and treatment technologies are helping address unmet needs.
Weakness: Being rare cancer type, lack of awareness and diagnosis remains key challenges. Long term outcomes are still suboptimal with high mortality rates.
Opportunity: Expanding targeted therapy options and improving survival rates presents lucrative opportunities. Scope for development of new combination regimens and pipeline candidates.
Threats: High cost of newer biologics poses reimbursement challenges. Entry of generics impacting sales of leading brands over forecast period.
Key Takeaways
The Global Bile Duct Cancer Market Size is expected to witness high growth over the forecast period of 2023 to 2030 owing to rising prevalence and improving access to advanced care. The global Bile Duct Cancer Market is estimated to be valued at US$ 235.9 Mn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030.
The North America region holds the highest market share currently due to favorable reimbursement policies supporting access to premium drugs as well as presence of major pipeline assets. Asia Pacific is expected to grow at highest CAGR during forecast period with China and India emerging as high potential markets. This can be attributed to increasing healthcare expenditure, expanding patient pool and adoption of advanced therapeutics at lower costs compared to developed nations.
Key players operating in the Bile Duct Cancer are Incyte Corporation, Eisai Co., Ltd., QED Therapeutics, Inc., Agios Pharmaceuticals, Inc., RenovoRx, Ability Pharmaceuticals, Imbrium Therapeutics L.P. and Delcath Systems, Inc. These companies are investing in clinical trials evaluating new targets and combination regimens to address unmet needs and capture higher market share over the coming years. Partnerships and licensing agreements with regional players also enhance geographical access and commercialization scope.
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.